Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Gains from Investment Securities: 2023-2024

Historic Gains from Investment Securities for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $1.1 million.

  • Zenas BioPharma's Gains from Investment Securities fell 90.27% to $619,000 in Q3 2025 from the same period last year, while for Mar 2025 it was $115,153, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2024, which is 1000.00% up from last year.
  • Per Zenas BioPharma's latest filing, its Gains from Investment Securities stood at $1.1 million for FY2024, which was up 1,000.00% from $100,000 recorded in FY2023.
  • In the past 5 years, Zenas BioPharma's Gains from Investment Securities registered a high of $1.1 million during FY2024, and its lowest value of $100,000 during FY2023.
  • Moreover, its 2-year median value for Gains from Investment Securities was $600,000 (2023), whereas its average is $600,000.
  • Data for Zenas BioPharma's Gains from Investment Securities shows a peak YoY soared of 1,000.00% (in 2024) over the last 5 years.
  • Over the past 2 years, Zenas BioPharma's Gains from Investment Securities (Yearly) stood at $100,000 in 2023, then surged by 1,000.00% to $1.1 million in 2024.